GENEKAL INDEX 



701 



Alkali excess, in acid-base balance of 

 the blood, uncompensated, iv, 72. 



uncompensated, iv, 68. 



Alkali retention test for alkali deficit, 

 iv, 81. 



Alkali therapy, in diabetes, iii, 316, 

 734. 



in nephritis, iii, 793. 



reaction of urine in, attention to, 



iii, 793. 



as routine before and after sur- 

 gical procedures, iii, 793. 



See Alkaine Treatment. 

 Alkalies, action of, iii, 227. 



administration of, to man, effect of, 

 iii, 334. 



-effect of, on absorption, iii, 318. 



on metabolism, iii, 732. 



in acidosis, iii, 734. 



of infants during diarrhea, 



iii, 735. 



in anesthesia, iii, 734. 



in diabetes, iii, 734. 



in retention acidosis, iii, 735. 



in uranium nephritis, iii, 735. 



neutrality regulation, iii, 732. 



in human body, iii, 315. 

 Alkaline condition of intestines, in 



metabolic disturbances of infancy, 



iv, 784. 

 Alkaline treatment, of acidosis, iii, 734, 



792. 



of anesthesia, iii, 734. 



of infants during diarrhea, iii, 



735. 

 retention, iii, 735. 



in gout, iii, 739. 



of uranium nephritis, iii, 735. 

 Alkaline-saline waters, effect of, on 



gastric secretion, iii, 848. 

 Alkaline waters, carbonated, effect of, 

 on gastric mucosa, iii, 848. 



effect of, on gastric secretion, iii, 

 848. 



on metabolism, iii, 849. 



on pancreatic secretion, iii, 849. 



therapeutic value of, iii, 850. 



Alkalinity, effect on, of purins, iii, 

 780. 



Alkalinization of urine, iii, 849. 



Alkalinuria, iv, 461. 



Alkalosis, in progressive muscular dys- 

 trophy, iv, 724. 



with creatinuria, iv, 724. 



with hypoglycemia, iv, 724. 

 Alkapton, formation of, in body, iv, 



506. 

 table of alkapton formers, iv, 507. 



Alkaptonuria, and consanguinity, iv, 

 502. 



character of, iv, 501. 



definition of, iv, 501. 



intestinal bacterial origin, objec- 

 tions to, iv, 508. 



properties of alkapton formers in 

 body, iv, 508. 



table of alkapton formers, iv, 507. 



transformation of tyrosin to ho- 

 mogentisic acid, iv, 507. 



-history of, iv, 503. 



hypothesis of, as due to closure of 

 one of two paths normally followed 

 by aromatic amino acids, iv, 511. 



as due to failure to break down 

 homogentisic molecule, iv, 510. 



metabolic findings in, iv, 513. 



occurrence of, iv, 501, 503. 



oxidation in and benzol ring, iv, 511, 

 51o. 



prognosis in, iv, 514. 



relationship between ocronosis and, 

 iv, 514. 



substances influencing excretion of, 

 iv, 509. 



symptoms of, iv, 501. 



table showing daily H : N ratios, iv, 

 512. 



treatment of, iv, 514. 



urine of, black, iv, 501. 



glycosuric acid in, iv, 503. 



homogentisic acid in, iv, 503. 



amount excreted, iv, 511. 



formation of, iv, 508. 



a pathological process, iv, 



510. 



formula for, iv, 504. 



synthesis of, Baumann and 

 Frankel, iv, 504. 



- Neubauer and Falta, iv, 506. 



Osborne, iv, 505. 

 transformation of tyrosin to, 

 iv, 507. 



isolation of substances in, iv, 503. 



protocatechinic acid in, iv, 503. 



pyrocatechol in, iv, 503. 



substances in, iv, 503. 



uroleucic acid in, iv, 503. 

 Allantoin, formula for, iv, 414. 



relation of, to uric acid, iv, 414. 

 Allen method of starvation in diabetes, 



iv, 26. 



Alloxuric bases, iv, 413. 

 Aloin, effect of, on metabolism, iii, 719. 

 Alopecia, thyroid treatment of, i, 105. 

 Altitude, and circulatory mechanism,. 



iii, 910. 



